Scientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has ...

Scientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has ...

An update from bioAffinity Technologies, Inc. ( ($BIAF) ) is now available. On December 3, 2025, bioAffinity Technologies announced that it will ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...

ACS--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced that Chief Medical Officer ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

STEMCELL Technologies and Immudex have announced the launch of a new protocol that combines the power of the EasySep Release positive selection platform with Immudex's Dextramer® reagents, enabling ...

Of the 11 patients treated with BE-CAR7 T cells, seven are in remission, including one patient who has been in remission for three years.

In November, The Lancet published an international expert consensus review, "Contemporary, non-invasive imaging diagnosis of ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide, highlighting the need for precise, non-invasive diagnostic tools.

Background Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often excluded from functional cure studies. Objective This study investigates CD8+ T ...